ATE376672T1 - Verfahren zur diagnose von multipler sklerose - Google Patents

Verfahren zur diagnose von multipler sklerose

Info

Publication number
ATE376672T1
ATE376672T1 AT03784432T AT03784432T ATE376672T1 AT E376672 T1 ATE376672 T1 AT E376672T1 AT 03784432 T AT03784432 T AT 03784432T AT 03784432 T AT03784432 T AT 03784432T AT E376672 T1 ATE376672 T1 AT E376672T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
diagnosing multiple
diagnosing
glycans
antibodies
Prior art date
Application number
AT03784432T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Schwarz
Ari Gargir
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Application granted granted Critical
Publication of ATE376672T1 publication Critical patent/ATE376672T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03784432T 2002-08-02 2003-08-04 Verfahren zur diagnose von multipler sklerose ATE376672T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US44707603P 2003-02-13 2003-02-13
US46298403P 2003-04-15 2003-04-15
US47323103P 2003-05-23 2003-05-23

Publications (1)

Publication Number Publication Date
ATE376672T1 true ATE376672T1 (de) 2007-11-15

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784432T ATE376672T1 (de) 2002-08-02 2003-08-04 Verfahren zur diagnose von multipler sklerose

Country Status (18)

Country Link
US (2) US7537900B2 (de)
EP (1) EP1529216B1 (de)
JP (2) JP4721703B2 (de)
AT (1) ATE376672T1 (de)
AU (1) AU2003263409B2 (de)
BR (1) BR0313194A (de)
CA (1) CA2494422A1 (de)
CY (1) CY1107859T1 (de)
DE (1) DE60317070T2 (de)
DK (1) DK1529216T3 (de)
ES (1) ES2297248T3 (de)
IL (1) IL166539A (de)
MX (1) MXPA05001270A (de)
NO (1) NO20051024L (de)
NZ (1) NZ585114A (de)
PL (1) PL210512B1 (de)
PT (1) PT1529216E (de)
WO (1) WO2004015420A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (de) 2003-12-03 2010-06-02 Glycominds Ltd. Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln
JP2008504531A (ja) * 2004-06-24 2008-02-14 ザ スクリップス リサーチ インスティテュート 切断可能なリンカーを有するアレイ
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
EP2517727A3 (de) * 2005-09-29 2013-10-30 Caprion Proteomics USA, LLC Biomarker für multiple Sklerose und Verfahren zu ihrer Verwendung
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
KR20160132034A (ko) 2014-03-13 2016-11-16 우니페르시테트 바젤 미엘린-관련 당단백질에 대한 IgM 항체와 결합하는 탄수화물 리간드
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
US11091591B2 (en) 2015-09-16 2021-08-17 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
AU2017286979B2 (en) 2016-07-01 2023-04-27 Dignity Health Diagnostic or predictor of relapsing remitting multiple sclerosis
WO2019195448A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
NZ513533A (en) * 1999-02-17 2003-11-28 Glycominds Ltd Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
CN1406153A (zh) * 2000-01-10 2003-03-26 基因谱公司 线性探针载体
AU2001288431A1 (en) 2000-08-28 2002-03-13 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
US20040077023A1 (en) 2004-04-22
CA2494422A1 (en) 2004-02-19
WO2004015420A8 (en) 2004-09-10
NZ585114A (en) 2011-09-30
US7537900B2 (en) 2009-05-26
IL166539A0 (en) 2006-01-15
WO2004015420B1 (en) 2004-04-29
AU2003263409B2 (en) 2010-05-27
EP1529216A1 (de) 2005-05-11
JP4721703B2 (ja) 2011-07-13
ES2297248T3 (es) 2008-05-01
JP2006501441A (ja) 2006-01-12
EP1529216B1 (de) 2007-10-24
JP2009258138A (ja) 2009-11-05
US20100081160A1 (en) 2010-04-01
IL166539A (en) 2010-11-30
CY1107859T1 (el) 2013-06-19
AU2003263409A1 (en) 2004-02-25
MXPA05001270A (es) 2005-08-03
DE60317070D1 (de) 2007-12-06
DE60317070T2 (de) 2008-07-24
NO20051024L (no) 2005-05-02
BR0313194A (pt) 2005-07-12
WO2004015420A1 (en) 2004-02-19
PT1529216E (pt) 2008-01-30
PL374869A1 (en) 2005-11-14
PL210512B1 (pl) 2012-01-31
DK1529216T3 (da) 2008-02-25

Similar Documents

Publication Publication Date Title
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
DE602006019206D1 (de) Verfahren zur diagnose von multipler sklerose
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
ATE427695T1 (de) Stoffwechseluberwachung, verfahren und gerat zur anzeige eines gesundheitsbezogenen zustands einer person
WO2004113896A3 (en) System and method for analysis of a biological fluid by the use electrical means
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
DE602004010432D1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und interleukin 6
DE60217351D1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
DE60317484D1 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
ATE299589T1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
ATE485060T1 (de) Verfahren zur diagnose von infektionskrankheiten
DE50105263D1 (de) Verfahren zur analyse von proteinen
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
ATE403877T1 (de) Verfahren zur untersuchung der aktivität von ionenkanälen
ATE278184T1 (de) Verfahren zur analyse einer biologischen probe
DE602007008581D1 (de) Verfahren zur bestimmung des antigengehalts in einer probe unter verwendung eines immunhistochemischen doppelnachweises
ATE246809T1 (de) Verfahren zur bestimmung der alkoholkonsumrate
DE602004011505D1 (de) Verfahren zur chromatographischen analyse einer proteinlösung
ATE404949T1 (de) Wasserzeichen für ein komprimiertes informationssignal
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
ATE244298T1 (de) Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1529216

Country of ref document: EP